These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33928619)

  • 1. A multicenter clinical study with myo-inositol and alpha-lactalbumin in Mexican and Italian PCOS patients.
    Hernandez Marin I; Picconi O; Laganà AS; Costabile L; Unfer V
    Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3316-3324. PubMed ID: 33928619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women.
    Montanino Oliva M; Buonomo G; Calcagno M; Unfer V
    J Ovarian Res; 2018 May; 11(1):38. PubMed ID: 29747700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of women with PCOS using myo-inositol and folic acid. New clinical data and review of the literature.
    Regidor PA; Schindler AE; Lesoine B; Druckman R
    Horm Mol Biol Clin Investig; 2018 Mar; 34(2):. PubMed ID: 29498933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential insulin response to oral glucose tolerance test (OGTT) in overweight/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both.
    Genazzani AD; Prati A; Marchini F; Petrillo T; Napolitano A; Simoncini T
    Gynecol Endocrinol; 2019 Dec; 35(12):1088-1093. PubMed ID: 31304823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome.
    Kamenov Z; Gateva A; Dinicola S; Unfer V
    Metabolites; 2023 May; 13(6):. PubMed ID: 37367875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.
    Pizzo A; Laganà AS; Barbaro L
    Gynecol Endocrinol; 2014 Mar; 30(3):205-8. PubMed ID: 24351072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients.
    Stracquadanio M; Ciotta L; Palumbo MA
    Gynecol Endocrinol; 2018 Jun; 34(6):495-501. PubMed ID: 29265900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.
    Artini PG; Di Berardino OM; Papini F; Genazzani AD; Simi G; Ruggiero M; Cela V
    Gynecol Endocrinol; 2013 Apr; 29(4):375-9. PubMed ID: 23336594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H; Xing C; Zhang J; He B
    Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Myo-inositol on Anthropometric, Metabolic, and Endocrine Outcomes in PCOS Patients: a Meta-analysis of Randomized Controlled Trial.
    Jethaliya H; Gajjar N; Patel V; Deshpande S; Patel R
    Reprod Sci; 2022 Aug; 29(8):2282-2298. PubMed ID: 35477841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome.
    Genazzani AD; Lanzoni C; Ricchieri F; Jasonni VM
    Gynecol Endocrinol; 2008 Mar; 24(3):139-44. PubMed ID: 18335328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGB1 is increased in adolescents with polycystic ovary syndrome (PCOS) and decreases after treatment with myo-inositol (MYO) in combination with alpha-lipoic acid (ALA).
    Cirillo F; Catellani C; Lazzeroni P; Sartori C; Tridenti G; Vezzani C; Fulghesu AM; Madeddu E; Amarri S; Street ME
    Gynecol Endocrinol; 2020 Jul; 36(7):588-593. PubMed ID: 32054355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
    Zacchè MM; Caputo L; Filippis S; Zacchè G; Dindelli M; Ferrari A
    Gynecol Endocrinol; 2009 Aug; 25(8):508-13. PubMed ID: 19551544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An innovative approach to polycystic ovary syndrome.
    Bizzarri M; Logoteta P; Monastra G; Laganà AS
    J Obstet Gynaecol; 2022 May; 42(4):546-556. PubMed ID: 34169781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of myo-inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial.
    Jamilian M; Farhat P; Foroozanfard F; Afshar Ebrahimi F; Aghadavod E; Bahmani F; Badehnoosh B; Jamilian H; Asemi Z
    Clin Endocrinol (Oxf); 2017 Aug; 87(2):194-200. PubMed ID: 28485095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet Plus Inositols, α-Lactalbumin and
    Basciani S; Nordio M; Dinicola S; Unfer V; Gnessi L
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.
    Genazzani AD; Prati A; Santagni S; Ricchieri F; Chierchia E; Rattighieri E; Campedelli A; Simoncini T; Artini PG
    Gynecol Endocrinol; 2012 Dec; 28(12):969-73. PubMed ID: 22612517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Combined therapy myo-inositol plus D-Chiro-inositol, in a physiological ratio, reduces the cardiovascular risk by improving the lipid profile in PCOS patients.
    Minozzi M; Nordio M; Pajalich R
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):537-40. PubMed ID: 23467955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.
    Costantino D; Minozzi G; Minozzi E; Guaraldi C
    Eur Rev Med Pharmacol Sci; 2009; 13(2):105-10. PubMed ID: 19499845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.